CMS Modified NCD 44 for Blood Platelet Transfusions, Effective January 9, 2026 — What Billing Teams Need to Know

TL;DR: The Centers for Medicare & Medicaid Services modified NCD 44, the National Coverage Determination governing blood platelet transfusion coverage under Medicare, with an effective date of January 9, 2026. Here's what changes for billing teams.

CMS blood platelet transfusion coverage policy under NCD 44 in the CMS Medicare system has been updated. The policy confirms blood platelet transfusions — including treatment for thrombocytopenia and related blood defects — as covered services when reasonable and necessary for the individual patient. This coverage applies across inpatient hospital, outpatient hospital, and physician service settings. No specific CPT or HCPCS codes are listed in this version of the policy.

Quick-Reference Table

CMS Blood Platelet Transfusion Coverage Criteria and Medical Necessity Requirements 2026

NCD 44 is the National Coverage Determination governing Medicare coverage of blood platelet transfusions. The coverage policy is straightforward on its face: CMS covers blood platelet transfusions when treatment is reasonable and necessary for the individual patient.

The policy specifically names thrombocytopenia and other blood defects as covered indications. Thrombocytopenia — a condition where platelet counts drop dangerously low — is the primary clinical driver for these transfusions. The "other blood defects" language gives some flexibility, but that flexibility cuts both ways.

Here's the real issue: "reasonable and necessary" is doing a lot of heavy lifting in this policy. That phrase is Medicare's standard coverage threshold, but it means your documentation has to connect the dots. A low platelet count alone doesn't close the claim. You need the clinical record to show why the transfusion was medically necessary for this specific patient at this specific time.

The coverage policy applies across three benefit categories: inpatient hospital services, outpatient hospital services incident to a physician's service, and physicians' services. That breadth matters for billing teams managing multiple care settings. The same medical necessity standard applies regardless of where the transfusion takes place.

CMS does not list prior authorization as a requirement under NCD 44. That said, prior auth requirements can still apply at the Medicare Administrative Contractor level depending on your region, or through Medicare Advantage plans that sit on top of this NCD. Check with your MAC if you're seeing prior authorization requests on these claims — it's not a national requirement, but it may be a local one.

Reimbursement for blood platelet transfusions follows Medicare's standard fee schedule under the applicable care setting. Inpatient claims fold into DRG payment. Outpatient claims typically process under the Outpatient Prospective Payment System. Know your setting before you bill — the reimbursement pathway differs significantly.

Coverage Indications at a Glance

CMS Blood Platelet Transfusion Billing Guidelines and Action Items 2026

The modification to NCD 44 took effect January 9, 2026. Here's what your billing team should do now.

CPT, HCPCS, and ICD-10 Codes for Blood Platelet Transfusions Under NCD 44

Covered CPT Codes (When Medical Necessity Criteria Are Met)

NCD 44 does not list specific CPT or HCPCS codes. CMS has not enumerated procedure codes in this version of the policy.

Work with your coding team to identify the correct transfusion procedure codes for your billing system. Common code families used for blood product transfusions include CPT codes in the transfusion medicine range and HCPCS codes for blood products — but map to your MAC's published guidance, not assumptions. A missing or incorrect procedure code is one of the most common drivers of claim denial on transfusion claims.

Key ICD-10-CM Diagnosis Codes

NCD 44 does not list specific ICD-10-CM codes. The policy references thrombocytopenia and other blood defects as covered indications. Your coding team should assign the most specific ICD-10-CM diagnosis code supported by the clinical documentation. Relevant diagnosis families include codes for thrombocytopenia and coagulation defects — but code to the actual documented condition, not the policy language.

What This Policy Modification Actually Means

This is a modification, not a new policy. NCD 44 has existed for years. The January 9, 2026 update signals CMS reviewed and maintained this coverage — but that doesn't mean nothing changed.

Modified NCDs sometimes carry subtle language shifts that change coverage scope or documentation expectations even when the summary reads as largely the same. Without a line-by-line diff of the prior version against the current version, you can't be certain what moved. That's not a hypothetical risk — it's a documentation gap.

The absence of specific codes in this policy is the most operationally relevant detail for blood platelet billing. It puts the burden on your team to map the right procedure codes, validate them against MAC guidance, and confirm your charge capture reflects current practice. If you haven't validated your transfusion procedure code mapping recently, do it before billing claims with a January 9, 2026 or later date of service.

If your practice or facility has significant volume in hematology or oncology — or if you manage inpatient billing for a hospital with active oncology service lines — this policy affects a meaningful slice of your claims. Talk to your compliance officer about whether your current documentation templates meet the "reasonable and necessary" standard under the updated NCD 44 coverage policy.